Search
for
Sort by
Research 31–60 of 351
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration
- Abstracts from the 2024 WDS Forum - virtual option
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Editor's Highlights — September 2024
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Current Insight of Peptide-Based Hydrogels for Chronic Wound Healing Applications: A Concise Review
- The Role of Natural Hydrogels in Enhancing Wound Healing: From Biomaterials to Bioactive Therapies
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Neuropeptídeos na pele
- Exploring the role of two polypeptide nanofiber gels derived from RADA16-I self-assembly in accelerating burn wound healing
- Semaglutide and the Skin: An Overview of Current Evidence
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Neuroendokrine paraneoplastische Syndrome
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- The clinical spectrum of parathyroid disease
- Endocrinologia e Medicina Estética Ed. X
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ